Indian drugmaker Cipla tops Q2 profit view on solid domestic, N.America sales
Bengaluru: Cipla, India’s third-largest generic drugmaker by sales, posted a bigger-than-expected rise in second-quarter profit on Friday, boosted by strength
Read moreBengaluru: Cipla, India’s third-largest generic drugmaker by sales, posted a bigger-than-expected rise in second-quarter profit on Friday, boosted by strength
Read moreBoston: An injected version of Eisai and Biogen‘s Alzheimer‘s drug Leqembi works as well as the current intravenous administration at
Read moreThe WHO regulatory considerations touch on the importance of establishing safety and effectiveness in AI tools, making systems available to
Read moreNew Delhi: The Supreme Court has recently said that to apply the principles of Res Ipsa Loquitur, it is necessary
Read moreShanghai: Chinese drugmaker Sichuan Kelun Pharmaceutical Co said on Monday that Merck & Co Inc was abandoning the joint development
Read moreAhmedabad: Fake antibiotic drugs worth Rs 17.5 lakh and used to treat serious diseases have been seized in raids across
Read moreLondon: UK private online pharmacy Rightangled was offering Novo Nordisk’s diabetes drug Ozempic for sale on Friday to people wanting
Read moreNew Delhi: A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the
Read moreMumbai: The concept of robots has fascinated humans for centuries. According to various mythologies, God created humans in his own
Read moreNew Delhi: The National Medical Commission (NMC) recently halted the mandate for doctors to prescribe only generic drugs or face
Read more